Abbott Laboratories on Thursday said Alere Inc. had agreed to turn over documents related to three government investigations into potential bribery and billing violations, as the future of the health care companies’ $5.8 billion merger continues to hang in the balance.
Abbott and Alere had filed dueling lawsuits over the deal, with Alere accusing Abbott of trying to escape the merger agreement and Abbott countering that Alere was concealing important details about the probes, which only came to light after the merger was announced in early February.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
